Clin2
NCT06773364Possibly a fitRecruiting

Early levetiracetam and head position for stroke

Suspected Stroke

Treatments studied

Part of Brain & nervous system, Heart & circulation clinical trials.

This trial tests if starting a seizure medication called levetiracetam early in the ambulance, along with a specific head position, can help people having a stroke. It is for adults who show clear stroke signs within the last 2 hours and do not have other major health problems.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
2,423 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years or older.
  • You must have signs of a stroke (like face drooping, arm weakness, or speech trouble) that started less than 2 hours ago, and you must have a weak arm.
  • You must be awake and able to respond (not in a coma).
  • You cannot have a history of epilepsy or had a seizure when the stroke started.
  • You cannot have a serious illness like advanced cancer, severe heart failure, or need help with daily activities before the stroke.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07336992Not yet recruiting· Phase 3
Levetiracetam to improve recovery after brain bleed

This trial tests whether giving a drug called levetiracetam (which is normally used to prevent seizures) soon after a type of stroke called a brain bleed (intracerebral haemorrhage) can improve recovery. It is a randomised, double-blind trial, meaning half the participants get the drug and half get a placebo (a dummy pill), and neither you nor the doctors know which one you are taking.

Bron
NCT06851078Not yet recruiting· Phase 3
Testing early seizure drug for brain protection in septic shock

This trial tests whether giving the seizure medication levetiracetam early can prevent or treat brain problems in people with septic shock. Septic shock is a life-threatening infection that can affect the brain, and this study aims to see if this drug helps protect brain function.

NCT06866691Recruiting· Phase 4
Seizure prevention after traumatic brain injury

This trial tests two medicines, levetiracetam and lacosamide, to see which works better at preventing seizures in people who have had a traumatic brain injury. The goal is to find the safest and most effective way to protect your brain after injury.

Winston-Salem, North Carolina
NCT07507097Not yet recruiting
Best head position for severe stroke patients

This study tests if the angle of a patient's head after a severe stroke affects recovery. It is for people who have had a first-time severe stroke and received clot-busting treatment or clot removal within 24 hours.

Chengdu, Sichuan
NCT05897658Not yet recruiting· Phase 3
Levetiracetam to prevent seizures after brain tumor surgery

This trial tests whether taking levetiracetam (a medicine used to prevent seizures) around the time of brain tumor surgery can reduce the chance of postoperative seizures. It may help people who are having surgery in the brain area where seizures are a known risk.

NCT05610085Recruiting· Phase 2
Levetiracetam for newborn seizures: dose-finding study

This trial studies how to give levetiracetam to newborn babies with seizures. It’s trying to find a safe dose and see if it can help control seizures in early life.

San Diego, California

Hear when a new Suspected Stroke trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.